Shuttle Pharmaceuticals ...

NASDAQ: SHPH · Real-Time Price · USD
3.38
-0.12 (-3.43%)
At close: Aug 15, 2025, 10:00 AM

Shuttle Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
5.46K 6.81K 5.97K 60.83K
Gross Profit
-5.46K -6.81K -66.83K -60.83K
Operating Income
-7.7B -5.89M -2.34M -1.74M
Interest Income
38.14K 79.12K n/a n/a
Pretax Income
-9.14B -6.59M -5M -1.15M
Net Income
-9.14B -6.59M -3.1M -1.15M
Selling & General & Admin
1.39B 1.05M 1.07M 721.18K
Research & Development
3.62M 3.52M 1.05M 1.02M
Other Expenses
-1.39B 1.32M 224.72K -60.83K
Operating Expenses
7.69M 5.89M 2.34M 1.68M
Interest Expense
1.36M 2.6M 670.61K 50.79K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
7.7M 5.89M 2.34M 1.74M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
10.32M 15.91M 10.35M 13.59M
Shares Outstanding (Diluted)
10.32M 15.91M 10.35M 13.59M
EPS (Basic)
-885.73 -0.41 -0.3 -0.09
EPS (Diluted)
-885.73 -0.41 -0.3 -0.09
EBITDA
-7.78M -3.99M -4.32M -1.04M
EBIT
-7.78M -4M -4.33M -1.1M
Depreciation & Amortization
5.46K 6.81K 5.97K 60.83K